Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Elite, Mikah in Generic Supply Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Elite, Mikah in Generic Supply Pact

Elite Pharmaceuticals, Inc. has entered into a commercial manufacturing and supply agreement with Mikah Pharma, LLC. Elite will perform the lab stability studies, manufacturing and packaging for two generic products, Isradipine Capsules USP, and Phendimetrazine Tartrate Tablets.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Elite Pharmaceuticals, Inc. has entered into a commercial manufacturing and supply agreement with Mikah Pharma, LLC. Elite will perform the lab stability studies, manufacturing and packaging for two generic products, Isradipine Capsules USP, and Phendimetrazine Tartrate Tablets.

Elite will receive an undisclosed fee upon transfer for the manufacturing and packaging of the products. For Isradipine, Elite will receive a 10% royalty on profits of the finished products. Elite will also receive a milestone payment for each product for the work associated with the technology transfer.

“The Mikah agreement represents Elite’s continuing progress in utilizing our manufacturing infrastructure and expertise to generate revenues,” said Jerry Treppel, chairman and chief executive officer.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics